Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suparna Mazumder

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Oncotarget|June 6, 2020
Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor IISuparna Mazumder, Valerie Swank, Anton A Komar, et al.
Nucleic Acids Research|September 12, 2013
Defective chromatin recruitment and retention of NHEJ core components in human tumor cells expressing a Cyclin E fragmentPayel Chatterjee, Dragos Plesca, Suparna Mazumder, et al.
Oncotarget|August 8, 2022
Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor IISuparna Mazumder, Valerie Swank, Anton A Komar, et al.
Molecular and Cellular Biology|March 9, 2002
Proteolytic cleavage of cyclin E leads to inactivation of associated kinase activity and amplification of apoptosis in hematopoietic cellsSuparna Mazumder, Bendi Gong, Quan Chen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 3, 2017
Primary Immunoprevention of Epithelial Ovarian Carcinoma by Vaccination against the Extracellular Domain of Anti-Müllerian Hormone Receptor IISuparna Mazumder, Justin M Johnson, Valerie Swank, et al.
Cancers|June 21, 2016
Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast CancerVincent K Tuohy, Ritika Jaini, Justin M Johnson, et al.
Oncotarget|July 30, 2015
Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimeticsGaurav S Choudhary, Trinh T Tat, Saurav Misra, et al.
Cureus|March 1, 2024
Efficacy and Safety of Oral Metronomic Chemotherapy in Recurrent Refractory Advanced Gynaecological Cancer: An Experience From the Regional Cancer Centre of Eastern IndiaRanti Ghosh, Kalyan Kusum Mukherjee, Ranajit Mandal, et al.
Ecancermedicalscience|June 11, 2025
Bevacizumab in recurrent epithelial ovarian cancer: real-world experience from a tertiary cancer hospital in IndiaRanti Ghosh, Debarshi Lahiri, Debjit Ghosh, et al.
Journal of Immunology Research|December 1, 2015
Regulation of Murine Ovarian Epithelial Carcinoma by Vaccination against the Cytoplasmic Domain of Anti-Müllerian Hormone Receptor IICagri Sakalar, Suparna Mazumder, Justin M Johnson, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Oncotarget|June 6, 2020
Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor IISuparna Mazumder, Valerie Swank, Anton A Komar, et al.
Nucleic Acids Research|September 12, 2013
Defective chromatin recruitment and retention of NHEJ core components in human tumor cells expressing a Cyclin E fragmentPayel Chatterjee, Dragos Plesca, Suparna Mazumder, et al.
Oncotarget|August 8, 2022
Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor IISuparna Mazumder, Valerie Swank, Anton A Komar, et al.
Molecular and Cellular Biology|March 9, 2002
Proteolytic cleavage of cyclin E leads to inactivation of associated kinase activity and amplification of apoptosis in hematopoietic cellsSuparna Mazumder, Bendi Gong, Quan Chen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 3, 2017
Primary Immunoprevention of Epithelial Ovarian Carcinoma by Vaccination against the Extracellular Domain of Anti-Müllerian Hormone Receptor IISuparna Mazumder, Justin M Johnson, Valerie Swank, et al.
Cancers|June 21, 2016
Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast CancerVincent K Tuohy, Ritika Jaini, Justin M Johnson, et al.
Oncotarget|July 30, 2015
Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimeticsGaurav S Choudhary, Trinh T Tat, Saurav Misra, et al.
Cureus|March 1, 2024
Efficacy and Safety of Oral Metronomic Chemotherapy in Recurrent Refractory Advanced Gynaecological Cancer: An Experience From the Regional Cancer Centre of Eastern IndiaRanti Ghosh, Kalyan Kusum Mukherjee, Ranajit Mandal, et al.
Ecancermedicalscience|June 11, 2025
Bevacizumab in recurrent epithelial ovarian cancer: real-world experience from a tertiary cancer hospital in IndiaRanti Ghosh, Debarshi Lahiri, Debjit Ghosh, et al.
Journal of Immunology Research|December 1, 2015
Regulation of Murine Ovarian Epithelial Carcinoma by Vaccination against the Cytoplasmic Domain of Anti-Müllerian Hormone Receptor IICagri Sakalar, Suparna Mazumder, Justin M Johnson, et al.
Pageof 3